SIRT3 and neoplasm: Though the administration of 4HR would inhibit the growth of tumor, elevated SIRT3 and SIRT6 could play a protective role for cancer cells that survived after 4HR treatment, and these cancer cells might be more resistant to other cytotoxic cancer therapy.